These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 24555586)
1. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586 [TBL] [Abstract][Full Text] [Related]
2. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients. Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581 [TBL] [Abstract][Full Text] [Related]
3. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET. Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862 [TBL] [Abstract][Full Text] [Related]
4. Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT. Evangelista L; Panunzio A; Cervino AR; Vinante L; Al-Nahhas A; Rubello D; Muzzio PC; Polverosi R J Med Imaging Radiat Oncol; 2012 Aug; 56(4):417-24. PubMed ID: 22883649 [TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
8. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748 [TBL] [Abstract][Full Text] [Related]
9. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG. Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618 [TBL] [Abstract][Full Text] [Related]
10. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT. Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020 [TBL] [Abstract][Full Text] [Related]
12. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules? Lohrmann C; Weber WA Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199 [TBL] [Abstract][Full Text] [Related]
13. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules. Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285 [TBL] [Abstract][Full Text] [Related]
14. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
15. Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers? Chundru S; Wong CY; Wu D; Balon H; Palka J; Chang CY; Gaskill M; Cheng CY; Huang WS; Fink-Bennett D Nucl Med Commun; 2008 Jul; 29(7):623-7. PubMed ID: 18528184 [TBL] [Abstract][Full Text] [Related]
16. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT. Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma. Watanabe S; Yano F; Kita T; Soga S; Shinmoto H; Kosuda S; Ozeki Y; Aida S; Sakata I Ann Nucl Med; 2008 Jul; 22(6):521-4. PubMed ID: 18670859 [TBL] [Abstract][Full Text] [Related]
18. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887 [TBL] [Abstract][Full Text] [Related]
19. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer. Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426 [TBL] [Abstract][Full Text] [Related]